E-PaperSun Pharma Q4 News
Sun Pharma’s March quarter results indicate a patchy road to recovery
As the company re-routed India distribution to its own entity, domestic sales slumped 44% last quarterAs domestic business normalizes, the management expects revenues to expand in low to mid-teens in FY20
2 min read30 May 2019Sun Pharma shares jump over 7%, market cap rises by Rs7,951 crore
Sun Pharma shares closes at Rs499.70 on BSE, up 7.11%its biggest gains since 6 April 2015, after the company reports its first profit growth in six quarters
2 min read28 May 2018Will Sun Pharma’s shareholders get a peek of sunshine in FY19?
The worst may be over for Sun Pharma, it appears from the Q4 results, and also from the management's guidance of a low double-digit growth in FY19. Still, investors will remain cautious
2 min read28 May 2018Sun Pharma Q4 profit rises 7% to Rs1,309 crore, beats estimates
Sun Pharma net profit rose 7% to Rs1,308.96 crore in the three months ended 31 March, from Rs1,223.71 crore in the year-ago quarter
1 min read25 May 2018Sun Pharma Q4 profit declines 14% to Rs1,223.71 crore on weak US sales
Sun Pharma's net sales fell 8% to Rs6,825.16 crore during the March quarter from Rs7,415.98 crore in the corresponding period a year ago
1 min read27 May 2017Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared